CellGenix is a leading global supplier of high quality raw and ancillary materials for the expanding market of cell and gene therapy and regenerative medicine.

It develops, manufacture and market human cytokines, growth factors, and other recombinant cell culture components in preclinical and GMP quality as well as proprietary serum-free media for further manufacturing of ATMPs. Its products are used by academia and industry partners in clinical trials and commercial manufacturing throughout the world. As an ATMP developer and manufacturer it gained in-depth cell culture knowledge and superior regulatory expertise. With this unique background it understands the high requirements that its customers face during product development and the regulatory approval process.

CellGenix is headquartered in Freiburg, Germany and operates a subsidiary near Boston in Portsmouth, USA.